» Articles » PMID: 19193910

Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop

Overview
Specialty Endocrinology
Date 2009 Feb 6
PMID 19193910
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Background: At the Third International Workshop on Asymptomatic Primary Hyperparathyroidism (PHPT) in May 2008, recent data on the disease were reviewed. We present the results of a literature review on issues arising from the clinical presentation and natural history of PHPT.

Methods: Questions were developed by the International Task Force on PHPT. A comprehensive literature search for relevant studies was reviewed, and the questions of the International Task Force were addressed by the Consensus Panel.

Conclusions: 1) Data on the extent and nature of cardiovascular involvement in those with mild disease are too limited to provide a complete picture. 2) Patients with mild PHPT have neuropsychological complaints. Although some symptoms may improve with surgery, available data remain inconsistent on their precise nature and reversibility. 3) Surgery leads to long-term gains in spine, hip, and radius bone mineral density (BMD). Because some patients have early disease progression and others lose BMD after 8-10 yr, regular monitoring (serum calcium and three-site BMD) is essential in those followed without surgery. Patients may present with normocalcemic PHPT (normal serum calcium with elevated PTH concentrations; no secondary cause for hyperparathyroidism). Data on the incidence and natural history of this phenotype are limited. 4) In the absence of kidney stones, data do not support the use of marked hypercalciuria (>10 mmol/d or 400 mg/d) as an indication for surgery for patients. 5) Patients with bone density T-score -2.5 or less at the lumbar spine, hip, or distal one third radius should have surgery.

Citing Articles

Influence of normocalcemic primary hyperparathyroidism in bone density alterations of the jaws in patients with periodontitis.

Garcia-Rueda S, Marquez-Arrico C, Herrero-Babiloni A, Silvestre-Rangil J, Silvestre F Med Oral Patol Oral Cir Bucal. 2024; 30(1):e151-e159.

PMID: 39582410 PMC: 11801675. DOI: 10.4317/medoral.26958.


Hypocalcemia in Patients With Osteoporosis and Normal Renal Function, Treated With Denosumab, a Retrospective Analysis.

Bitar Z, Hajjiah A, Maadarani O, Elzoueiry M, Gohar M, Abdelfatah M Nutr Metab Insights. 2024; 17:11786388231223604.

PMID: 38205220 PMC: 10775727. DOI: 10.1177/11786388231223604.


Comparison of Medical Management versus Parathyroidectomy in Patients with Mild Primary Hyperparathyroidism: A Meta-Analysis.

Cironi K, Issa P, Albuck A, McCarthy C, Rezvani L, Hussein M Cancers (Basel). 2023; 15(12).

PMID: 37370696 PMC: 10296026. DOI: 10.3390/cancers15123085.


Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis.

Rajput S, Dutta A, Rajender S, Mithal A, Chattopadhyay N Front Endocrinol (Lausanne). 2023; 14:1098841.

PMID: 36817591 PMC: 9931892. DOI: 10.3389/fendo.2023.1098841.


Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen.

Regidor P, Mueller A, Mayr M Womens Health (Lond). 2023; 19:17455057221147388.

PMID: 36744531 PMC: 9905034. DOI: 10.1177/17455057221147388.


References
1.
Baim S, Binkley N, Bilezikian J, Kendler D, Hans D, Lewiecki E . Official Positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Position Development Conference. J Clin Densitom. 2008; 11(1):75-91. DOI: 10.1016/j.jocd.2007.12.007. View

2.
Tordjman K, Greenman Y, Osher E, Shenkerman G, Stern N . Characterization of normocalcemic primary hyperparathyroidism. Am J Med. 2004; 117(11):861-3. DOI: 10.1016/j.amjmed.2004.06.037. View

3.
Valdemarsson S, Lindergard B, Tibblin S, Bergenfelz A . Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease. J Intern Med. 1998; 243(2):115-22. DOI: 10.1046/j.1365-2796.1998.00241.x. View

4.
Abugassa S, Nordenstrom J, Eriksson S, Mollerstrom G, ALVERYD A . Skeletal remineralization after surgery for primary and secondary hyperparathyroidism. Surgery. 1990; 107(2):128-33. View

5.
Ogard C, Sondergaard S, Vestergaard H, Jakobsen H, Nielsen S . Myocardial perfusion defects and the left ventricular ejection fraction disclosed by scintigraphy in patients with primary hyperparathyroidism. World J Surg. 2005; 29(7):914-6. DOI: 10.1007/s00268-005-7740-1. View